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OBJECTIVES The goal of this study was to evaluate the effect of preconditioning on out-of-hospital
ventricular fibrillation (VF) in patients with acute myocardial infarction (AMI).
BACKGROUND More than half of the deaths associated with AMI occur out of the hospital and within 1 h
of symptom onset. In humans, preinfarction angina (PA), which can serve as a surrogate
marker for preconditioning, reduces infarct size, but the protective effect against out-of-
hospital VF has not been investigated.
METHODS Preinfarction angina status and acute coronary angiographic findings of 72 consecutive
patients with AMI complicated by out-of-hospital VF were compared with 144 matched
controls without this complication.
RESULTS Preinfarction angina is associated with a lower risk for VF (odds ratio [OR]: 0.40, 95%
confidence interval [CI]: 0.18 to 0.88). In patients with acute occlusion of the left coronary
artery (LCA) (n  136), the risk reduction is pronounced (OR: 0.25, 95% CI: 0.10 to 0.66),
whereas, in patients with acute occlusion of the right coronary artery (RCA) (n  67), the
protective effect of PA on VF was not observed (OR: 2.25, 95% CI: 0.45 to 11.22). Subgroup
and multivariate analyses show that the protective effect is independent of cardiovascular risk
factors, preinfarction treatment with beta-adrenergic blocking agents or aspirin, the presence
of collaterals or residual antegrade flow or the extent of coronary artery disease.
CONCLUSIONS Preinfarction angina protects against out-of-hospital VF in patients with acute occlusion of
the LCA. This protection is independent of risk factors or coronary anatomy. A larger study
is needed to examine the apparently different effect in patients with acute occlusion of the
RCA. (J Am Coll Cardiol 2001;38:1369–74) © 2001 by the American College of
Cardiology
When the heart is subjected to a transient nonlethal period
of ischemia, it quickly adapts itself to become more resistant
to infarction due to a subsequent ischemic insult. This
adaptation is called preconditioning. In animal experiments,
preconditioning both reduces myocardial infarct size and
protects against life-threatening ventricular arrhythmias (1–
4). Although protective effects of preconditioning are clearly
demonstrated in humans (5), for both logistic and ethical
reasons, no clinical study can meet the strict conditions of
experimental studies on preconditioning with infarct size or
life-threatening arrhythmias as the end point. Clinical
studies on infarct size have demonstrated that preinfarction
angina (PA) can serve as a “marker” for preconditioning
(2,6), reduce infarct size (6–8) and protect against ventric-
ular arrhythmias after reperfusion therapy (9). To our
knowledge, the effect of preconditioning or PA against
life-threatening arrhythmias during the out-of-hospital
phase of acute myocardial infarction (AMI) has not been
studied in humans.
The demonstration of a beneficial effect of precondition-
ing in humans could have several important clinical impli-
cations (5,10,11) and provide a mandate for further study of
the cellular mechanisms and the translation into therapeutic
strategies (2). Because the most important cause of death
associated with AMI is out-of-hospital ventricular fibrilla-
tion (VF), a key question would be whether preconditioning
or PA can also protect against this lethal complication.
We previously reported a large case-control study of
survivors of out-of-hospital VF related to acute coronary
occlusion (12). In the present study we use this patient series
to test the hypothesis that PA protects against out-of-
hospital VF during AMI. Since we demonstrated that
patients with acute occlusion of the left coronary artery
(LCA) have a significantly higher risk for out-of-hospital
VF compared with patients who have acute occlusion of the
right coronary artery (RCA), we also analyzed the effect of
PA according to the site of occlusion.
METHODS
In De Weezenlanden Hospital, Zwolle, and in the Univer-
sity Hospital, Ghent, primary angioplasty is the treatment
of choice for complicated and uncomplicated AMI as long
as patients present within 6 h after symptom onset, have
electrocardiographic criteria for AMI (presence of ST seg-
ment elevation of more than 0.1 mV in at least two adjacent
leads of a 12-lead ECG or presence of a presumed new left
bundle branch block) and, for AMI cases complicated by
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out-of-hospital VF, have a reasonable chance to survive
without major neurological sequelae. Between January 1995
and December 1998, 72 survivors of out-of-hospital VF
fulfilled these criteria and were candidates for primary
angioplasty. Clinical and angiographic data were compared
with that of 144 controls matched for age, gender, admis-
sion hospital (Gent or Zwolle) and primary or secondary
admission (referred by a local community hospital after
diagnosis of AMI) as previously reported (12). In summary,
univariate analysis showed that patients with an acute
occlusion of the LCA (left anterior descending artery or
circumflex artery) had a higher risk for out-of-hospital VF
compared with patients with an acute occlusion of the RCA
(odds ratio [OR] and 95% confidence interval [CI], respec-
tively, 4.82 [2.35 to 9.92] and 4.92 [2.34 to 10.39]).
Multivariate analysis showed that only acute occlusion of
the LCA was significantly associated with out-of-hospital
VF. Flow grade in the infarct-related artery (IRA) or
presence of an additional (chronic) occlusion in a non-IRA
were both of borderline significance as predictors of out-of-
hospital VF. In this study, we further specify preinfarction
medication and medical history including family history of
coronary artery disease (CAD) and history of hypertension,
diabetes mellitus, hypercholesterolemia and current smok-
ing. The timing of onset of angina before MI in relation to
outcome is unknown in humans (13). In previous clinical
studies, the timing ranged between 24 h and one month
(8,14–18). In a prospective temporal analysis of onset of PA
and its effect on outcome, angina that occurred within 24 h
was more protective than PA occurring later than 24 h (13).
In an experimental study, the optimal interval between
ischemic preconditioning stimulus and the prolonged epi-
sode occurred between 24 h and 72 h (19). Therefore, in this
study, we arbitrarily defined PA by the presence of at least
one period of chest pain occurring within the 72 h preceding
the AMI. Chronic angina is defined as documented symp-
tomatic CAD or typical chest pain occurring at least one
month remote from the AMI. These data were entered
prospectively for the patients of De Weezenlanden Hospital
(n  150) and were retrospectively collected by reviewing
the medical records for the patients of University Hospital,
Ghent (n  66).
Statistical analysis. Univariate analysis of categorical vari-
ables was carried out by a two-tailed Fisher exact test.
Descriptive variables with a normal distribution were given
by mean and SD, and means were compared using t test.
Tests for heterogeneity of subgroups were carried out by
Breslow-Day test. Multivariate analysis for prediction of
out-of-hospital VF was carried out using logistic regression
analysis (SPSS release 7.5).
RESULTS
Relation between PA and VF. Data on PA status were
documented in 66 of the 72 patients with VF (91.6%) and
in 137 of the 144 controls (95.2%). Patients with undocu-
mented PA status were excluded from further analysis.
Preinfarction angina is associated with a lower risk for VF
(OR: 0.40, 95% CI: 0.18 to 0.88). Preinfarction angina was
present in 13.6% of patients with VF compared with 28.5%
of controls (p  0.02) (Table 1).
Relation between PA and VF according to the site of
acute coronary occlusion. In patients with acute occlusion
of the LCA (n 136), PA protected against VF (OR: 0.25,
95% CI: 0.10 to 0.66) (Fig. 1). In patients with acute
occlusion of the RCA (n  67), PA was not significantly
associated with VF (OR: 2.25, 95% CI: 0.45 to 11.22). The
effect of PA against VF differed significantly according to
the site of occlusion (Breslow-Day test for heterogeneity:
p  0.014) (Fig. 1). Coronary history (chronic angina or
prior MI) and coronary risk factors of patients with acute
occlusion of the LCA were comparable to those with acute
occlusion of the RCA; however, the latter were significantly
older and had more preinfarction hypertension (Table 2).
Clinical characteristics and coronary anatomy of patients
with PA. Preinfarction angina was not associated with the
presence of risk factors, the extent of CAD (multivessel
disease or jeopardy score), the history of MI or the presence
Abbreviations and Acronyms
AMI  acute myocardial infarction
CAD  coronary artery disease
CI  confidence interval
IRA  infarct-related coronary artery
LCA  left coronary artery
MI  myocardial infarction
OR  odds ratio
PA  preinfarction angina
RCA  right coronary artery
VF  ventricular fibrillation




VF (n  66)
Patients Without
Out-of-Hospital
VF (n  137)
p
Value*
Men 51 (77.3%) 107 (78.1%) 1.00
Age 55.7 ( 10.2) 56.7 ( 10.3) 0.52
Family history 30 (46.9%) 63 (46.0%) 1.00
Current smoking 30 (46.9%) 65 (52.0%) 0.54
Hypertension 17 (26.2%) 30 (21.9%) 0.60
Hypercholesterolemia 11 (17.2%) 27 (20.3%) 0.70
Diabetes mellitus 5 (7.7%) 4 (2.9%) 0.15
Chronic angina 9 (13.6%) 17 (12.7%) 0.83
Preinfarction angina 9 (13.6%) 39 (28.5%) 0.02
History of MI 5 (7.6%) 11 (8.1%) 1.00
Medication before MI
Beta-blocker 5 (7.7%) 16 (12.0%) 0.46
Aspirin 4 (6.2%) 14 (10.5%) 0.43
*According to two-tailed Fisher exact test. Data presented are number (%) of patients
or mean  SD.
MI  myocardial infarction; VF  venticular fibrillation.
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of chronic occlusions (Table 3). Patients with PA had more
chronic angina (22.9% vs. 9.9%, p  0.03) and used
beta-adrenergic blocking agents and aspirin more frequently
(respectively, 16.7% vs. 8.7% and 18.8% vs. 6.0%). The IRA
of patients with PA had antegrade flow more frequently
(Thrombolysis In Myocardial Infarction [TIMI] flow
Figure 1. Graph showing on a logarithmic scale the odds ratios and 95% confidence intervals for out-of-hospital ventricular fibrillation associated with
preinfarction angina in various subgroups. *Hypertension, hypercholesterolemia, diabetes mellitus, current smoking and family history. IRA 
infarct-related coronary artery; LCA left coronary artery; PA preinfarction angina; RCA right coronary artery; TIMI Thrombolysis In Myocardial
Infarction; VF  ventricular fibrillation.
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grade  0, p  0.02) and had more collaterals (p  0.04)
than patients without PA (Table 3).
Relation of PA to out-of-hospital VF in subgroups of
patients with occlusion of the LCA. Preinfarction angina
also reduces the risk of VF in predefined subgroups of
patients with occlusion of the LCA (Fig. 1). The protective
effect of PA against VF is observed in patients with or
without collaterals to the IRA, in patients with or without
antegrade flow in the IRA, in patients with a large area at
risk (region at risk  3) and in patients with and without
extensive CAD (respectively, jeopardy score 3 or 4).
The protective effect was also present in patients who were
not treated with beta-blockers or aspirin before the onset of
MI, in patients with multiple coronary risk factors, in
patients younger or older than 55 years and in patients with
or without chronic angina.
Multivariate analysis of the effect of PA against VF in
patients with acute occlusion of the LCA. We included
all clinical and angiographic variables in a multivariate
model to predict VF in patients with acute occlusion of the
LCA. Variables included were: PA, age, gender, chronic
angina, previous MI, hypertension, diabetes mellitus, hy-
percholesterolemia, current smoking, family history, num-
ber of diseased vessels, jeopardy score, acute occlusion of the
LAD, proximal acute occlusion, region at risk, TIMI flow
grade 0 and presence of collaterals. In the model, PA was
the only significant predictor of VF (adjusted OR  0.20,
p  0.007), which demonstrates that in patients with acute
occlusion of the LCA, PA has a protective effect on VF
independent of the former clinical and angiographic vari-
ables.
DISCUSSION
In this case-control study, we confirm the hypothesis that
PA protects against out-of-hospital VF during AMI (OR:
0.40, 95% CI: 0.18 to 0.88). Absence of PA is significantly
associated with out-of-hospital VF. Moreover, we found the
protective effect of PA to depend on the site of occlusion. In
patients with acute occlusion of the LCA, there is a strong
protective effect of PA against VF (OR: 0.25, 95% CI: 0.10
to 0.66). In patients with acute occlusion of the RCA, the
effect of PA is significantly different (p 0.014). Due to the
low number of patients with VF and acute occlusion of the
RCA (n  7), a larger study is needed to specify the effect
of PA in this subgroup.
Protective effect of PA against out-of-hospital VF in
patients with acute occlusion of the LCA. To our knowl-
edge, this is the first study that tests the hypothesis that PA
protects against VF during the out-of-hospital phase of MI
in humans. Patients with angina during 48 h preceding their
AMI have lower rates of in-hospital VF after thrombolytic
treatment (9,15). Previous studies have also shown a pro-
tective effect of preconditioning on the occurrence of com-
plex ventricular premature beats during acute coronary
occlusion in the setting of percutaneous transluminal coro-
nary angioplasty (20) or during ST segment elevation in
patients with variant angina (21).
Animal experiments have confirmed that preconditioning
protects against VF during acute coronary occlusion
(3,4,22–24). The confirmation of this protective effect
during acute coronary occlusion in humans invites further
research as early VF is the major cause of death in patients
with AMI. The case fatality of AMI is still between 25%
and 55%, the proportion of out-of-hospital death varies
between 67% and 91% (inversely related to age [25]), and
out-of-hospital death during AMI is mainly related to early
VF (26). Moreover, at this point, preconditioning can also
be simulated or inhibited by pharmacologic interventions in
humans (5,11). For instance, sulphonylureas for patients
Table 2. Clinical Characteristics According to Site of Acute
Occlusion
Occlusion of
LCA (n  136)
Occlusion of
RCA (n  67)
p
Value*
Men 109 (80.1%) 49 (73.1%) 0.28
Age 55.1 ( 10.2) 58.9 ( 10.0) 0.01
Family history 60 (44.4%) 33 (50.0%) 0.55
Current smoking 63 (48.8%) 32 (53.3%) 0.64
Hypertension 25 (18.5%) 22 (32.8%) 0.03
Hypercholesterolemia 22 (16.8%) 16 (24.2%) 0.25
Diabetes mellitus 6 (4.4%) 3 (4.5%) 1.00
Chronic angina 18 (13.5%) 8 (11.9%) 0.83
Preinfarction angina 30 (22.1%) 18 (26.9%) 0.48
History of MI 11 (8.2%) 5 (7.5%) 1.00
Medication before MI
Beta-blocker 11 (8.3%) 10 (15.2%) 0.15
Aspirin 12 (9.1%) 6 (9.1%) 1.00
*According to two-tailed Fisher exact test. Data presented are number (%) of patients
or mean  SD.
LCA  left coronary artery; MI  myocardial infarction; RCA  right coronary
artery; VF  ventricular fibrillation.
Table 3. Clinical and Angiographic Characteristics of Patients
With and Without Preinfarction Angina
Patients With
PA (n  48)
Patients Without
PA (n  155)
p
Value*
Men 37 (77.1%) 121 (78.1%) 0.85
Age 57.0 ( 9.9) 56.1 ( 10.4) 0.59
Family history 27 (56.3%) 66 (43.1%) 0.14
Current smoking 18 (40.9%) 77 (53.1%) 0.17
Hypertension 14 (29.2%) 33 (21.4%) 0.33
Hypercholesterolemia 13 (27.1%) 25 (16.8%) 0.14
Diabetes mellitus 2 (4.2%) 7 (4.5%) 1.00
Chronic angina 11 (22.9%) 15 (9.9%) 0.03
History of MI 4 (8.3%) 12 (7.8%) 1.00
Beta-blocker 8 (16.7%) 13 (8.7%) 0.18
Aspirin 9 (18.8%) 9 (6.0%) 0.02
Multivessel disease 23 (47.9%) 60 (38.7%) 0.31
Jeopardy score  3 11 (22.9%) 31 (20.0%) 0.69
Chronic occlusion 10 (6.5%) 4 (8.3%) 0.75
Proximal occlusion 18 (37.5%) 58 (37.4%) 1.00
TIMI flow grade  0 23 (47.9%) 45 (29.0%) 0.02
Collaterals 20 (41.7%) 39 (25.2%) 0.04
*According to two-tailed Fisher exact test. Data presented are number (%) of patients
or mean  SD.
MI  myocardial infarction; PA  preinfarction angina; TIMI  Thrombolysis
In Myocardial Infarction; VF  ventricular fibrillation.
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with diabetes or methylxanthines inhibit the precondition-
ing pathways and, therefore, could be deleterious in patients
who are at risk for AMI. The increased mortality from
cardiovascular causes observed in diabetic patients on sul-
phonylureas in the UGDP trial (27) and the worse outcome
at the time of AMI (28) might be due to blockade of
preconditioning. Otherwise, preconditioning mechanisms
can pharmacologically be simulated by adenosine A1-
receptor agonists and K ATP channel openers (5).
The protective effect of PA can theoretically be mediated
by preconditioning mechanisms, formation of collaterals or
better preservation of antegrade flow in the IRA (5).
Subgroup and multivariate analyses (Fig. 1) indicate that the
protection against VF does not depend on the presence of
collaterals or antegrade flow rate in the IRA. Therefore, our
data strongly support animal (3,4,22–24) and human
(20,21) studies in which preconditioning exerted an antiar-
rhythmic effect during prolonged coronary occlusion.
The effect of PA on out-of-hospital VF depends on site
of occlusion. The significantly different effect of PA
against VF in patients with acute occlusion of the RCA is an
unexpected finding (Fig. 1 and Breslow-Day test, p 
0.014). It would be overly cautious to deduce from this
finding that PA does not have a protective effect against
out-of-hospital VF, because only seven of the 67 patients
with out-of-hospital VF presented with acute occlusion of
the RCA. The different effect of PA against VF in these
patients (OR: 2.25, 95% CI: 0.45 to 11.22) has to be
confirmed in larger studies. To our knowledge, this finding
was not reported in animal experiments. One hypothesis to
explain this finding is that PA attenuates the vagal reflexes
associated with the occlusion of the RCA and, therefore,
aborts the vagal-mediated protection against VF during
acute occlusion of the RCA. Inferior-wall infarctions induce
vagal reflexes more often than infarctions located at other
sites (29), and vagal tone protects against VF during AMI
(30–32). Brief periods of ischemia attenuate extreme auto-
nomic reactions (33), and patients with angina have atten-
uated vagal tone (34) and less severe bradyarrhythmias
compared with those without PA (35). Therefore, PA
might abort the vagal-mediated protection against VF that
specifically occurs during occlusion of the RCA. Another
hypothesis to explain this finding is that there is an
age-related reduction of ischemic preconditioning (36).
Patients with acute occlusion of the RCA in this study are
older compared with patients with acute occlusion of the
LCA (58.9 vs. 55.1 years, p  0.01).
Study limitations. The major limitation of retrospective
studies of survivors of out-of-hospital VF is the possibility
of information bias. In survivors of out-of-hospital VF, the
presence of PA could be under-reported due to retrograde
anamnesia or due to the possibly lower sensitivity of
heteroanamnesis for the detection of PA. However, it is very
unlikely, and there are no theoretical grounds that under-
reporting of PA occurs significantly more frequently in VF
patients with occlusion of the LCA than in VF patients
with occlusion of the RCA. We found a significantly
different effect according to the site of occlusion. Therefore,
the lower incidence of PA in survivors of out-of-hospital VF
with occlusion of the LCA cannot be attributed to under-
reporting.
The second limitation is the relatively low number of
patients. Although this is the largest consecutive series of
survivors of out-of-hospital VF with angiography during
AMI, there are too few patients to study the effect of the
time interval between the last period of PA and the onset of
MI and the effect of PA on out-of-hospital VF in patients
with acute occlusion of the RCA.
The third limitation of this study is the potential for
selection bias. Every study on out-of-hospital VF in humans
with AMI is threatened by potential selection bias. The
study group (out-of-hospital VF) does not include patients
with VF in whom resuscitation was not successful. The
control group does not include victims of AMI complicated
by sudden cardiac death not related to out-of-hospital VF
(asystole, severe bradyarrhythmias and electromechanical
dissociation). In order to explain our first finding (PA
protects against VF) by selection bias only, one had to
assume that PA reduces the success rate of resuscitation for
VF. To the best of our knowledge, there are no data
supporting this assumption. Moreover, in our study, the
presence of PA was not associated with more severe CAD
(jeopardy score, number of diseased vessels) or larger region
at risk for infarction. On the contrary, it was associated with
more collaterals and better flow in the IRA. Therefore, the
effect of selection bias on our first finding is very unlikely. In
order to explain our second finding (the effect of PA against
VF differs according to the site of occlusion) by selection
bias only, one had to assume that PA increases the success
rate of resuscitation for VF in patients with occlusion of the
RCA. Although there are no data directly supporting this
assumption, it is known that PA in patients with RCA
occlusion protects against right ventricular infarction and is
associated with lower in-hospital mortality (35). Therefore,
the effect of selection bias on our second finding cannot be
excluded.
Conclusions. This is the first study in humans that has
addressed the effect of PA on VF during acute coronary
occlusion. Preinfarction angina protects against out-of-
hospital VF in patients with acute occlusion of the LCA.
This protection is independent of cardiovascular risk factors,
presence of collaterals or flow in the IRA or the extent of
CAD. To determine the specific effects of PA in patients
with acute occlusion of the RCA, a larger study is needed.
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